|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.9 TWD | +0.51% |
|
+0.51% | -4.69% |
G&E Herbal Biotechnology Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 64.61 million compared to TWD 24.57 million a year ago. Net income was TWD 7.38 million compared to net loss of TWD 19.88 million a year ago.
Basic earnings per share from continuing operations was TWD 0.13 compared to basic loss per share from continuing operations of TWD 0.36 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.69% | 100M | |
| +35.04% | 5.92B | |
| -15.13% | 4.51B | |
| -9.75% | 3.15B | |
| +2.14% | 3.1B | |
| -6.82% | 2.42B | |
| +47.87% | 1.97B | |
| -7.89% | 1.68B | |
| +0.09% | 1.65B | |
| -12.97% | 1.53B |
G&E HERBAL BIOTECHNOLOGY CO., LTD. 
